Section Arrow
Quote
RSLS.NASDAQ
- ReShape Lifesciences Inc
(Financial Status)
Quotes are at least 15-min delayed:2025/01/21 05:30 EST
Last
 4.52
-0.15 (-3.21%)
Day High 
4.859 
Prev. Close
4.67 
1-M High
5.19 
Volume 
21.79K 
Bid
4.35
Ask
4.6
Day Low
4.52 
Open
4.8 
1-M Low
4.09 
Market Cap 
3.41M 
Currency USD 
P/E 0.06 
%Yield -- 
10-SMA 4.73 
20-SMA 4.61 
50-SMA 5.06 
52-W High 29 
52-W Low 4.09 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
77.26/-16.50
Enterprise Value
3.56M
Balance Sheet
Book Value Per Share
2.04
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
8.68M
Operating Revenue Per Share
14.31
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed：2025/01/21 05:30 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.